Skip to main content

Table 1 Characteristics of enrolled patients with congenital heart disease

From: Preoperative thyroid hormone levels predict ICU mortality after cardiopulmonary bypass in congenital heart disease patients younger than 3 months old

Characteristic

All patients (n = 133)

Age (days)

36.56 ± 26.78

 ≤28 days

50 (37.6 %)

 >28 days and ≤ 90 days

83 (62.4 %)

Gender

 Male

89 (66.9 %)

 Female

44 (33.1 %)

Weight (kg)

3.89 ± 0.91

RACHS-1

 Score-1

4 (3.0 %)

 Score-2

46 (34.6 %)

 Score-3

44 (33.1 %)

 Score-4

38 (28.6 %)

 Score-5

1 (0.7 %)

 Score-6

0(0 %)

Type of Surgery

 ASD

2 (1.5 %)

 VSD

12 (9.0 %)

 VSD + ASD

50 (37.6 %)

 COA/IAA

15(11.3 %)

 TAPVC

21(15.8 %)

 TGA

19 (14.3 %)

 PA-VSD

3 (2.2 %)

 DORV

2 (1.5 %)

 Other

9 (6.8 %)

Operative factors

 CPB time (min)

114.23 ± 81.98

 ACC time (min)

46.03 ± 21.59

ICU mortality

13 (9.8 %)

Preoperative serum albumin (g/L)

38.23 ± 4.87

Preoperative thyroid function

 FT3 (pmol/L)

4.99 ± 1.54

 FT4 (pmol/L)

21.28 ± 5.82

 TT3 (nmol/L)

1.87 ± 0.56

 TT4 (nmol/L)

120.25 ± 34.61

 TSH (µIU/ml)

5.72 ± 5.95

  1. RACHS-1 Risk Adjustment in Congenital Heart Surgery-1, ASD atrial septal defect, VSD ventricular septal defect, COA coarctation of aorta, IAA interrupter aortic arch, TAPVC total anomalous pulmonary venous connection, TGA transposition of the great arteries, PA pulmonary atresia, DORV double outlet right ventricular, CPB cardiopulmonary bypass, ACC aortic cross-clamping, FT3 free triiodothyronine, FT4 free thyroxin, TT3 total triiodothyronine, TT4 total thyroxin, TSH thyroid stimulating hormone